Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure

Autonomic Neuroscience: Basic and Clinical

Volumn 156, Issue 1-2, 2010, Pages 27-35

  Kimura, Kensuke ^a   Kanazawa, Hideaki ^a   Ieda, Masaki ^a   Kawaguchi Manabe, Haruko ^a   Miyake, Yoshiko ^a   Yagi, Takashi ^a   Arai, Takahide ^a   Sano, Motoaki ^a   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Congestive heart failure; Nerve growth factor; Norepinephrine; Sympathetic denervation

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; NERVE GROWTH FACTOR; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; FLUID RETENTION; GENE EXPRESSION; HEART DENERVATION; HEART INNERVATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART PERFORMANCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE FIBER; NONHUMAN; OBSERVATION; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SYMPATHETIC NERVE;

ANIMALS; CHICKENS; HEART FAILURE; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; NERVE GROWTH FACTOR; NOREPINEPHRINE; RATS; RATS, WISTAR; SYMPATHECTOMY; SYMPATHETIC FIBERS, POSTGANGLIONIC;

EID: 77955271874     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.02.005     Document Type: Article

References (32)

1. Baker K.M., Chernin M.I., Wixson S.K., Aceto J.F. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 1990, 259:H324-H332.
2. Bohm M., La Rosee K., Schwinger R.H., Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J. Am. Coll. Cardiol. 1995, 25:146-153.
3. Cao J.M., Fishbein M.C., Han J.B., Lai W.W., Lai A.C., Wu T.J., Czer L., Wolf P.L., Denton T.A., Shintaku I.P., Chen P.S., Chen L.S. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circ. 2000, 101:1960-1969.
4. Chang P.C., Kriek E., van der Krogt J.A., van Brummelen P. Does regional norepinephrine spillover represent local sympathetic activity?. Hypertens. 1991, 18:56-66.
5. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., Simon A.B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J. Med. 1984, 311:819-823.
6. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A., Lambert G., Kaye D., Kopin I., Goldstein D., Esler M. Cardiac sympathetic nerve function in congestive heart failure. Circ. 1996, 93:1667-1676.
7. Hasking G.J., Esler M.D., Jennings G.L., Burton D., Korner P.I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circ. 1986, 73:615-621.
8. Henderson E.B., Kahn J.K., Corbett J.R., Jansen D.E., Pippin J.J., Kulkarni P., Ugolini V., Akers M.S., Hansen C., Buja L.M.. Abnormal I-123 metaiodo-benzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circ. 1988, 78:1192-1199.
9. Heumann R., Korsching S., Scott J., Thoenen H. Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. EMBO J. 1984, 3:3183-3189.
10. Himura Y., Felten S.Y., Kashiki M., Lewandowski T.J., Delehanty J.M., Liang C.S. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circ. 1993, 88:1299-1309.
11. Hjemdahl P. Catecholamine measurements by highperformance liquid chromatography. Am. J. Physisl. 1984, 247:E13-E20.
12. Ieda M., Fukuda K., Hisaka Y., Kimura K., Kawaguchi H., Fujita J., Shimoda K., Takeshita E., Okano H., Kurihara Y., Kurihara H., Ishida J., Fukamizu A., Federoff H.J., Ogawa S. Endothelin-1 regulates cardiac sympathetic innervations in the rodent heart by controlling nerve growth factor expression. J. Clin. Investig. 2004, 113:876-884.
13. Kaddoura S., Firth J.D., Boheler K.R., Sugden P.H., Poole-Wilson P.A. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Circ. 1996, 93:2068-2079.
14. Kanazawa H., Ieda M., Kimura K., Arai T., Kawaguchi-Manabe H., Endo J., Kawakami T., Kimura T., Monkawa T., Hayashi M., Iwanami A., Shimoda K., Okano H., Okada Y., Ishibashi-Ueda H., Ogawa S., Fukuda K. Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-mediated cytokines. J. Clin. Investig. 2010, 120:408-421.
15. Kawamoto S., Niwa H., Tashiro F., Sano S., Kondoh G., Takeda J., Tabayashi K., Miyazaki J. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett. 2000, 470:263-268.
16. Kaye D.M., Vaddadi G., Gruskin S.L., Du X.J., Esler M.D. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ. Res. 2000, 86:80-84.
17. Kimura K., Ieda M., Kanazawa H., Yagi T.K.T., Tsunoda M.N.S., Kurosawa H., Yoshimi K., Mochizuki H., Yamazaki K., Okada Y., Ogawa S., Fukuda K. Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ. Res. 2007, 100:1755-1764.
18. Kreusser M.M., Haass M., Buss S.J., Hardt S.E., Gerber S.H., Kinscherf R.K., Katus H.A., Backs J. Injection of nerve growth factor into stellate ganglia improves norepinephrine reuptake into failing hearts. Hypertens. 2006, 47:209-215.
19. Mabe A.M., Hoard J.L., Duffourc M.M., Hoover D.B. Localization of cholinergic innervation and neurturin receptors in adult mouse heart and expression of the neurturin gene. Cell Tissue Res. 2006, 326:57-67.
20. Matsushita N., Kobayashi K., Miyazaki J., Kobayashi K. Fate of transient catecholaminergic cell types revealed by site-specific recombination in transgenic mice. J. Neurosci. Res. 2004, 78:7-15.
21. Meredith I., Eisenhofer G., Lambert G., Dewar E., Jennings G., Esler M. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circ. 1993, 88:136-145.
22. Miyachi M., Yazawa H., Furukawa M., Tsuboi K., Ohtake M., Nishizawa T., Hashimoto K., Yokoi T., Kojima T., Murate T., Yokota M., Murohara T., Koike Y., Nagata K. Exercise training alters left ventricular geometry and attenuates heart failure in dahl salt-sensitive hypertensive rats. Hypertens. 2009, 53:701-707.
23. Okada M., Yamashita C., Okada M., Okada K. Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension. Circ. 1995, 92:114-119.
24. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J. Med. 1996, 334:1349-1355.
25. Pool P.E., Covell J.W., Levitt M., Gigg J., Braunwald E. Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure: its role in the depletion of cardiac norepinephrine stores. Circ. Res. 1967, 20:349-353.
26. Qin F., Vulapalli R.S., Stevens S.Y., Liang C.S. Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF. Am. J. Physiol. 2002, 282:H363-H371.
27. Rana O.R., Saygili E., Meyer C., Gemein C., Krüttgen A., Andrzejewski M.G., Ludwig A., Schotten U., Schwinger R.H.G., Weber C., Weis J., Mischke K., Rassaf T., Kelm M., Schauerte P. Regulation of nerve growth factor in the heart: The role of the calcineurin-NFAT pathway. J. Mol. Cell. Cardiol. 2009, 46:568-578.
28. Sano M., Fukuda K., Kodama H., Pan J., Saito M., Matsuzaki J., Takahashi T., Makino S., Kato T., Ogawa S. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J. Biol. Chem. 2000, 275:29717-29723.
29. Sheikh F., Raskin A., Chu P.H., Lange S., Domenighetti A.A., Zheng M., Liang X., Zhang T., Yajima T., Gu Y., Dalton N.D., Mahata S.K., Dorn G.W., Heller-Brown J., Peterson K.L., Omens J.H., McCulloch A.D., Chen J. An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J. Clin. Investig. 2008, 118:3870-3880.
30. Snider W.D. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994, 77:627-638.
31. Thomas J.A., Marks B.H. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 1978, 41:233-243.
32. Wang F., Seta Y., Baumgarten G., Engel D.J., Sivasubramanian N., Mann D.L. Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart. Circ. 2001, 103:1296-1302.